Jacobs & CO Edwards Lifesciences Corp Transaction History

Jacobs & CO

$1 Billion
Q3 2024

A detailed history of Jacobs & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Jacobs & CO holds 122,900 shares of EW stock, worth $8.05 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

122,900

Previous 113,021 8.74%

Holding current value

$8.05 Million

Previous $10.4 Million 22.31%

% of portfolio

0.81%

Previous 1.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	BUY	$59.7 - $93.78 $589,776 - $926,452	9,879 Added 8.74%	122,900 $8.11 Million
Q2 2024 Jul 12, 2024	BUY	$84.3 - $94.31 $20,232 - $22,634	240 Added 0.21%	113,021 $10.4 Million
Q1 2024 Apr 12, 2024	BUY	$72.54 - $95.56 $153,494 - $202,204	2,116 Added 1.91%	112,781 $10.8 Million
Q4 2023 Jan 17, 2024	BUY	$61.71 - $77.76 $212,714 - $268,038	3,447 Added 3.21%	110,665 $8.44 Million
Q3 2023 Oct 13, 2023	BUY	$69.28 - $93.38 $238,531 - $321,507	3,443 Added 3.32%	107,218 $7.43 Million
Q2 2023 Jul 11, 2023	BUY	$81.41 - $94.33 $89,225 - $103,385	1,096 Added 1.07%	103,775 $9.79 Million
Q1 2023 Apr 17, 2023	BUY	$74.26 - $84.51 $69,284 - $78,847	933 Added 0.92%	102,679 $8.49 Million
Q4 2022 Jan 13, 2023	BUY	$68.3 - $87.44 $300,315 - $384,473	4,397 Added 4.52%	101,746 $7.59 Million
Q3 2022 Oct 11, 2022	BUY	$82.37 - $107.29 $66,884 - $87,119	812 Added 0.84%	97,349 $8.04 Million
Q2 2022 Jul 19, 2022	SELL	$86.5 - $128.27 $512,945 - $760,641	-5,930 Reduced 5.79%	96,537 $9.18 Million
Q1 2022 Apr 14, 2022	SELL	$101.96 - $128.34 $303,331 - $381,811	-2,975 Reduced 2.82%	102,467 $12.1 Million
Q4 2021 Jan 21, 2022	SELL	$106.37 - $130.68 $139,344 - $171,190	-1,310 Reduced 1.23%	105,442 $13.7 Million
Q3 2021 Oct 13, 2021	SELL	$102.91 - $122.75 $244,514 - $291,654	-2,376 Reduced 2.18%	106,752 $12.1 Million
Q2 2021 Jul 15, 2021	SELL	$83.84 - $104.76 $369,734 - $461,991	-4,410 Reduced 3.88%	109,128 $11.3 Million
Q1 2021 Apr 05, 2021	SELL	$78.68 - $90.67 $94,730 - $109,166	-1,204 Reduced 1.05%	113,538 $9.5 Million
Q4 2020 Jan 12, 2021	SELL	$71.69 - $91.23 $18,711 - $23,811	-261 Reduced 0.23%	114,742 $10.5 Million
Q3 2020 Dec 03, 2020	BUY	$67.19 - $87.44 $138,008 - $179,601	2,054 Added 1.82%	115,003 $9.18 Million
Q2 2020 Jul 09, 2020	BUY	$57.54 - $76.95 $4.33 Million - $5.79 Million	75,187 Added 199.11%	112,949 $7.81 Million
Q1 2020 Apr 13, 2020	SELL	$52.41 - $81.0 $98,268 - $151,875	-1,875 Reduced 4.73%	37,762 $7.12 Million
Q4 2019 Jan 29, 2020	SELL	$71.7 - $82.09 $248,727 - $284,770	-3,469 Reduced 8.05%	39,637 $9.25 Million
Q3 2019 Nov 04, 2019	SELL	$61.55 - $75.43 $73,367 - $89,912	-1,192 Reduced 2.69%	43,106 $9.48 Million
Q2 2019 Aug 01, 2019	BUY	$55.74 - $64.41 $66,776 - $77,163	1,198 Added 2.78%	44,298 $8.18 Million
Q1 2019 Apr 29, 2019	BUY	$47.89 - $64.05 $2.06 Million - $2.76 Million	43,100 New	43,100 $8.25 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account